Loading company…
RenaissThera develops small-molecule therapies for cardio-metabolic diseases, including obesity and diabetes.
Founded in 2023, RenaissThera develops small-molecule therapies for cardio-metabolic diseases, including obesity and diabetes, using AI platforms for drug discovery. The company is based in Bangalore, India. In June 2026, it raised seed funding led by Arali Ventures to advance its oral pipeline and preclinical programs.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in